Among non-SCCs, only one primary tumor (<1 %) and none of the primary metastases or recurrent lesions had high NECTIN4 expression, yet the prevalence of tumors scoring 1+ was significantly highest in the recurrent lesions (p = 0.01) (Fig. 4C). This evidence concerns the gene NECTIN4 and neoplasm.